Venture Transactions in Connecticut

Oui Therapeutics develops digital therapeutics designed to provide life-saving interventions and support for patients. Oui Therapeutics was founded in 2018 and is based in New Haven, Connecticut.

Athyrium Capital Management
Investor
Asset Manager
New York, New York
www.athyrium.com

Polaris Partners
Investor
Growth Capital Firm
Boston, Massachusetts
www.polarispartners.com

Athletic Brewing Co. is an operator of a craft brewery intended to produce non-alcoholic beer. Athletic Brewing Co. was founded in 2017 and is based in Milford, Connecticut.

Alliance Consumer Growth (ACG)
Investor
Growth Capital Firm
New York, New York
www.acgpartners.com

AtlasXomics is a commercializing novel discovery platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases. AtlasXomics is based in New Haven, Connecticut.

Spring Mountain Capital
Investor
Growth Capital Firm
New York, New York
www.smcgrowthcapital.com

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer. SpringWorks Therapeutics was founded in 2017 and is based in Stamford, Connecticut.

HBM Partners
Investor
Private Equity Firm
Zug, Switzerland
www.hbmpartners.com

BVF Partners
Investor
Private Equity Firm
San Francisco, California
www.bvflp.com

ReNetX Bio mission is to provide first-in-class therapeutics to treat injury and damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma. The company was founded based on the innovative technology from Dr. Stephen Strittmatter's work at Yale University to restore neurologic function after CNS injury. ReNetX Bio is based in New Haven, Connecticut.

Spring Mountain Capital
Investor
Growth Capital Firm
New York, New York
www.smcgrowthcapital.com

Cybrexa Therapeutics is developing an entirely new class of therapeutics that directly targets the tumor microenvironment. Cybrexa is an oncology-focused platform technology company that enables antigen-independent targeting of tumors and metastases with deep tissue penetration for small molecule anti-cancer drugs. Cybrexa Therapeutics was founded in 2017 and is based in New Haven, Connecticut.

Advantage Capital Partners
Investor
Growth Capital Firm
New Orleans, Louisiana
www.advantagecap.com

IsoPlexis is a life sciences company developing a diagnostic platform that identifies a wide range of patient immune responses at the cellular level. Its platform can assess safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development and informing physician decisions. IsoPlexis was founded in 2013 and is based in Branford, Connecticut.

Ironwood Capital
Investor
Growth Capital Firm
Avon, Connecticut
www.ironwoodcap.com

Advantage Capital Partners
Investor
Growth Capital Firm
New Orleans, Louisiana
www.advantagecap.com

Evariant is a healthcare CRM platform combines digital marketing solutions, big data, and analytics to grow patient engagement and enable proactive care. Evariant was founded in Farmington, Connecticut.

Health Enterprise Partners
Investor
Private Equity Firm
New York, New York
www.hepfund.com

TradeBlock is a crypto index provider. TradeBlock offers advanced indexes and reference rates, consolidated APIs, historical trade and order-book data, and customizable algorithms. TradeBlock was founded in 2013 and is based in Stamford, Connecticut.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Continuum Rehabilitation is a provider of skilled nursing and home health care services. Continuum Rehabilitation is based in Avon, Connecticut.

Colchester Capital
Investor
Private Equity Firm
Berkeley Heights, New Jersey
www.colchestercapital.com

Loxo Oncology, Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. Loxo Oncology, Inc. was founded in 2013 and is based in Stamford, Connecticut.

Aisling Capital
Investor
Private Equity Firm
New York, New York
www.aislingcapital.com

Local Yokel Media is an online ad marketplace specializing in monetizing hyperlocal ad impressions. Local Yokel Media is based in Stamford, Connecticut.

Gold Ridge Asset Management
Investor
Private Equity Firm
Mount Pleasant, South Carolina
www.goldridgeasset.com

Trevi Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. Trevi Therapeutics was formed in 2011 and is based in New Haven, Connecticut.

TPG
Investor
Private Equity Firm
Fort Worth, Texas
www.tpg.com

New Haven Pharmaceuticals is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or are generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities.

Advantage Capital Partners
Investor
Growth Capital Firm
New Orleans, Louisiana
www.advantagecap.com

Emme is a provider of advanced environmental control and energy management products to the residential and light commercial markets. Emme was founded in 2012 and is based in Bristol, Connecticut.

Advantage Capital Partners
Investor
Growth Capital Firm
New Orleans, Louisiana
www.advantagecap.com

MedPricer.com, Inc. is a software-as-a-service (SaaS) provider of technology solutions that enable hospitals and other organizations to analyze, benchmark and source purchased services contracts independent of any existing group purchasing organization (GPO) affiliation. MedPricer.com was founded in 2008 and is based in Guilford, Connecticut.

Telegraph Hill Partners
Investor
Venture Capital Firm
San Francisco, California
www.thpartners.net